This finding is inconsistent with a report by Mu et al. [49] showing that patients with early-stage breast cancer and the T/T genotype or high intratumoral TGFβ1 levels had shorter OS times than did those without T/T or with low intratumorial TGFβ1 levels. The gene discussed is TGFB1; the disease is breast carcinoma.